|
insulin glargine Clinical Trials
3 actively recruiting trials across 1 location
▼ -1 trial since August 2026
Also known as: Adjust insulin dose according to fasting plasma glucose (FBG), Basaglar, Lantus, Semglee, Toujeo
Pipeline
Phase 3: 1Phase 4: 2
Top Sponsors
- The First Affiliated Hospital of Xiamen University1
- Nanjing First Hospital, Nanjing Medical University1
- Loyola University1
Indications
- Diabetes3
- Type 2 Diabetes Patients1
- Gestational Diabetes Mellitus, Class A21
- Diabetes Mellitus in Pregnancy1
- Hyperglycaemia (Diabetic)1
Other2 trials
Maywood, Illinois1 trial
RCT Glargine vs NPH for Treatment of DM in Pregnancy
Loyola University Medical Center
Phase 3
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.